88IV - PR Newswire Asia's news


Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships TAIPEI , July 27, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and ... 2026-07-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology. Offers 5x greater ... 2026-07-27T Biotechnology Computer/Electronics Health Care/Hospital Medical Equipment
Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors Presentation to feature first-in-human results for ISM6331, a novel, AI-designed pan-TEAD inhibitor targeting the Hippo pathway ... 2026-07-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565 CHENGDU, China , July 27, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that it has received ... 2026-07-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ascletis Announces Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, Demonstrated Superior Weight Loss in a Diet-Induced Obese Mouse Model -ASC37 demonstrated statistically significant 88% greater relative body weight reduction compared to tirzepatide in the diet-induced obese (DIO) mouse model. -Both ASC37 once-monthly subcutaneous (SQ) ... 2026-07-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Bambusa Therapeutics Reports Potentially Transformative Preliminary Proof-of-Concept Results for BBT001 in Atopic Dermatitis, Reinforcing Its Best-in-Disease Potential BBT001 delivered highly statistically significant and clinically meaningful improvement in EASI beginning at Week 1, with responses continuing to improve over time ... 2026-07-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development ... 2026-07-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Jiangxi Bio's Veterinary Tetanus Antitoxin Production Line Officially Commenced Production,Accelerating Commercialization of the Animal Antiserum Portfolio HONG KONG , July 27, 2026 /PRNewswire/ -- Jiangxi Institute of Biological Products Inc. and its subsidiaries (collectively, "Jiangxi Bio" or the "Group") (stock code: 6915.HK) is ... 2026-07-27T Agriculture Banking/Financial Service Biotechnology Health Care/Hospital
IHH Healthcare Expands 'IHH Catalyst' to North Asia to Accelerate Clinical Adoption of Healthcare Innovation Building on the success of its inaugural programme in India, IHH Healthcare is launching IHH Catalyst \| North Asia Edition to help startups in Hong Kong, Chinese Mainland and neighbouring markets turn ... 2026-07-27T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Seaweed extract shown to relieve prostate symptoms In a breakthrough clinical trial undertaken by Australian biotechnology company Marinova, a unique seaweed extract has been shown to relieve the symptoms of benign prostatic hyperplasia (BPH). ... 2026-07-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology